US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virax Biolabs Group Limited

0.9606

+0.04064.41%

Post-market: 0.9600-0.0006-0.06%19:53 EDT

Volume:371.25K

Turnover:362.41K

Market Cap:4.17M

PE:-0.59

High:1.04

Open:0.9500

Low:0.9310

Close:0.9200

Loading ...

Overview Company News Filings

Virax Biolabs Receives Nasdaq Notification for Minimum Bid Price Deficiency

Virax Biolabs Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

THOMSON REUTERS

Virax Biolabs Group Ltd. Unveils New Presentation on Next-Generation Immune Diagnostics for Chronic Inflammation and Immune Dysfunction

Virax Biolabs Reports Significant Drop in Revenues to $6,331 for FY 2025, Marking Sharp Decline from $156,419 in Previous Year

BRIEF-Virax Biolabs Group CFO Jason Davis To Resign

Virax Biolabs Group : CFO Jason Davis to Resign

THOMSON REUTERS

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

HC Wainwright Initiates Virax Biolabs at Buy With $3 Price Target

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers

BUZZ-H.C. Wainwright starts coverage on Virax Biolabs with 'buy' rating

Virax Biolabs Group Ltd : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $3

THOMSON REUTERS

Virax Biolabs initiated with a Buy at H.C. Wainwright

Virax Biolabs : Enrolls First Patients in Clinical Study Assessing T Cell Dysfunction in Post-Acute Infection Syndromes

THOMSON REUTERS

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency

BRIEF-Cosmos Health Signs Expanded Exclusive Distribution Agreement With Virax Biolabs For Avian Influenza Virus PCR Kits

Cosmos Health: Expanded Exclusive Distribution Agreement With Virax Biolabs for Avian Influenza Virus Pcr Kits in Saudi Arabia, UAE, Qatar, Kuwait

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VRAX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRAX\",,,,,undefined,":{"symbol":"VRAX","market":"US","secType":"STK","nameCN":"Virax Biolabs Group Limited","latestPrice":0.9606,"timestamp":1752868800000,"preClose":0.92,"halted":0,"volume":371248,"hourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":0.9606,"latestTime":"19:53 EDT","volume":9689,"amount":9126.8159,"timestamp":1752882780377},"delay":0,"floatShares":3676014,"shares":4341956,"eps":-1.624848,"marketStatus":"Closed","change":0.0406,"latestTime":"07-18 16:00:00 EDT","open":0.95,"high":1.04,"low":0.931,"amount":362407.86489888,"amplitude":0.118478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.624848,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":5,"adr":0,"listingDate":1658376000000,"exchange":"NASDAQ","adjPreClose":0.92,"preHourTrading":{"tag":"盘前","latestPrice":0.95,"preClose":0.92,"latestTime":"09:25 EDT","volume":1033,"amount":950.0052678000001,"timestamp":1752845100184},"postHourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":0.9606,"latestTime":"19:53 EDT","volume":9689,"amount":9126.8159,"timestamp":1752882780377},"volumeRatio":1.881219},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRAX\",,,,,undefined,":{"symbol":"VRAX","floatShares":3676014,"roa":"-64.68%","roe":"-114.47%","lyrEps":-1.624848,"volumeRatio":1.881219,"shares":4341956,"dividePrice":0,"high":1.04,"amplitude":0.118478,"preClose":0.92,"low":0.931,"week52Low":0.7387,"pbRate":"0.73","psRate":"658.80","week52High":8.9999,"institutionHeld":0,"latestPrice":0.9606,"eps":-1.624848,"divideRate":0,"volume":371248,"delay":0,"ttmEps":-1.624848,"open":0.95,"prevYearClose":2.25,"prevWeekClose":0.9,"prevMonthClose":0.7917,"prevQuarterClose":0.7917,"fiveDayClose":0.9,"twentyDayClose":0.82,"sixtyDayClose":0.9592},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRAX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552497782","title":"Virax Biolabs Receives Nasdaq Notification for Minimum Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2552497782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552497782?lang=en_us&edition=fundamental","pubTime":"2025-07-19 04:15","pubTimestamp":1752869720,"startTime":"0","endTime":"0","summary":"Virax Biolabs Group Ltd., a biotechnology company listed on NASDAQ under the symbol \"VRAX,\" has received a notification from The Nasdaq Stock Market LLC regarding a minimum bid price deficiency. According to a notice dated July 14, 2025, the company is not in compliance with NASDAQ Listing Rule 5550, which requires listed securities to maintain a minimum bid price of $1.00 per share. Virax has until January 12, 2026, to regain compliance by achieving a closing bid price of at least $1.00 for a minimum of ten consecutive business days. The company may also be eligible for an additional 180-day grace period if compliance is not met by the deadline. Despite the notification, Virax's shares will continue to trade uninterrupted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDLbP2H8g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRAX","BK4175","BK4583"],"gpt_icon":0},{"id":"2552497204","title":"Virax Biolabs Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2552497204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552497204?lang=en_us&edition=fundamental","pubTime":"2025-07-19 04:15","pubTimestamp":1752869701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nTUANGVYP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4175","BK4583","VRAX"],"gpt_icon":0},{"id":"2550663695","title":"Virax Biolabs Group Ltd. Unveils New Presentation on Next-Generation Immune Diagnostics for Chronic Inflammation and Immune Dysfunction","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663695","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663695?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:27","pubTimestamp":1752092836,"startTime":"0","endTime":"0","summary":"Virax Biolabs Group Ltd. Unveils New Presentation on Next-Generation Immune Diagnostics for Chronic Inflammation and Immune Dysfunction. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief on July 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL3QZNZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","VRAX","BK4583"],"gpt_icon":0},{"id":"2548487738","title":"Virax Biolabs Reports Significant Drop in Revenues to $6,331 for FY 2025, Marking Sharp Decline from $156,419 in Previous Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2548487738","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548487738?lang=en_us&edition=fundamental","pubTime":"2025-07-03 05:30","pubTimestamp":1751491823,"startTime":"0","endTime":"0","summary":"Virax Biolabs Reports Significant Drop in Revenues to $6,331 for FY 2025, Marking Sharp Decline from $156,419 in Previous Year. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL4mnlKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRAX"],"gpt_icon":0},{"id":"2543848630","title":"BRIEF-Virax Biolabs Group  CFO Jason Davis To Resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2543848630","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543848630?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:27","pubTimestamp":1749846434,"startTime":"0","endTime":"0","summary":"BRIEF-Virax Biolabs Group  CFO Jason Davis To ResignJune 13 (Reuters) - Virax Biolabs Group Ltd VRAX.O:VIRAX BIOLABS GROUP : CFO JASON DAVIS TO RESIGNFurther company coverage: VRAX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nFWN3SG0EG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","VRAX","BK4175"],"gpt_icon":0},{"id":"2543860630","title":"Virax Biolabs Group : CFO Jason Davis to Resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2543860630","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543860630?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:25","pubTimestamp":1749846359,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nFWN3SG0EG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRAX","BK4175","BK4583"],"gpt_icon":0},{"id":"2524071976","title":"Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2524071976","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524071976?lang=en_us&edition=fundamental","pubTime":"2025-04-01 02:57","pubTimestamp":1743447463,"startTime":"0","endTime":"0","summary":"H.C. Wainwright initiated coverage on Virax Biolabs Group Limited , a U.K.-based company focused on detecting immune responses and diagnosing viral diseases.Virax Biolabs is developing T cell-based test technologies to provide an immunology profiling platform. T-cell testing can be particularly effective in diagnosing and therapeutics for post-viral syndromes .Also Read: EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.’s HHS Goals On Vaccine Transparency. The ViraxImmune platform is developing an adaptable test to detect the body's immune response to various conditions associated with chronic inflammation and T-cell exhaustion. Utilizing peptide pools to activate memory T cells and measurespecific cytokine profiles related to various infections, ViraxImmune is designed to address multiple diseases and research needs.The ViraxImmune platform will be available initially for research use only  before in vitro diagnostics  approval. It can analyze the activation of cells involved in the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/virax-biolabs-investigational-diagnostic-tests-185743593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VRAX"],"gpt_icon":1},{"id":"2523587941","title":"HC Wainwright Initiates Virax Biolabs at Buy With $3 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2523587941","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523587941?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:52","pubTimestamp":1743425555,"startTime":"0","endTime":"0","summary":"HC Wainwright Initiates Virax Biolabs at Buy With $3 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VRAX"],"gpt_icon":0},{"id":"2523439339","title":"BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers","url":"https://stock-news.laohu8.com/highlight/detail?id=2523439339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523439339?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:48","pubTimestamp":1743421708,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL6N3QE0ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","IIPR","NVD2.UK","MRNA","SNVD.UK","LU0320765489.SGD","USAW.SI","NVD3.UK","NEM","NVDY","CRSP","NVDX","SRPT","LU2756315664.SGD","LU1066051225.USD","SLDB","2NVD.UK","NVDU","STLD","LU0511384066.AUD","NVIW.SI","MACW.SI","NVDS.UK","3NVD.UK","LU2054465674.USD","BLUE","LU2290526834.HKD","LU1720051017.SGD","VRAX","TSYW.SI","NVDD","NVDS","LU0788108826.HKD","NVDA","LU1732799900.SGD","SG9999014567.USD","AU","LU0203347892.USD","NVD","X","NMAX"],"gpt_icon":1},{"id":"2523129689","title":"BUZZ-H.C. Wainwright starts coverage on Virax Biolabs with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2523129689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523129689?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:58","pubTimestamp":1743418738,"startTime":"0","endTime":"0","summary":"BUZZ-H.C. Wainwright starts coverage on Virax Biolabs with 'buy' rating** H.C. Wainwright starts coverage on biotech firm Virax Biolabs VRAX.O with a \"buy\" rating and $3 PT, implying a more than twofold upside to stock's last close** VRAX has an \"attractive market opportunity\" in post-acute infection syndromes  diagnostics, with long COVID potentially contributing to a \"hundreds of millions of dollars\" market, says brokerage ** PAIS refers to chronic illnesses that occur after an infection, causing prolonged symptoms such as fatigue, pain and cognitive issues** ViraxImmune, a diagnostic test, is being developed to detect T-cell dysfunction in PAIS, including long COVID, with UK clinical validation study underway, brokerage says** The test shows promise in evaluating immune status in chronic conditions, with \"significant changes\" in cytokine levels, which are small proteins that help immune cells communicate, in PAIS patients - H.C. Wainwright** Over 16 million U.S. and UK patients are ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3N3QE0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRAX"],"gpt_icon":0},{"id":"2523911973","title":"Virax Biolabs Group Ltd : H.c. Wainwright Initiates Coverage With Buy Rating  and Target Price $3","url":"https://stock-news.laohu8.com/highlight/detail?id=2523911973","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523911973?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:28","pubTimestamp":1743416880,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4175","VRAX"],"gpt_icon":0},{"id":"2523119299","title":"Virax Biolabs initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2523119299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523119299?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:15","pubTimestamp":1743416146,"startTime":"0","endTime":"0","summary":"H.C. Wainwright initiated coverage of Virax Biolabs (VRAX) with a Buy rating and $3 price target Virax is a UK-based development-stage in vitro dia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/virax-biolabs-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/virax-biolabs-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4175","VRAX","BK4583"],"gpt_icon":0},{"id":"2520620435","title":"Virax Biolabs : Enrolls First Patients in Clinical Study Assessing T Cell Dysfunction in Post-Acute Infection Syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2520620435","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520620435?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:13","pubTimestamp":1742299997,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q1136:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRAX","BK4583","BK4175"],"gpt_icon":0},{"id":"2520624414","title":"Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2520624414","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520624414?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:30","pubTimestamp":1742297400,"startTime":"0","endTime":"0","summary":"LONDON, March 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited  , an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today that it has started enrolling patients into its United Kingdom based, multi-center clinical study .\"There are currently no reliable diagnostics for patients with these conditions associated with post-acute infection syndromes,\" said James Foster, CEO of Virax Biolabs, \"The data generated from this clinical study will provide additional insights into the immune dysregulation in these conditions, enabling us to improve diagnostics and patient care. ViraxImmune has the potential to improve the assessment of immune health, ultimately paving the way for earlier treatment intervention and better patient outcomes.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/virax-biolabs-enrolls-first-patients-113000148.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/virax-biolabs-enrolls-first-patients-113000148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VRAX","BK4175","POST","BK4583","BK4212"],"gpt_icon":0},{"id":"2519833899","title":"Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833899","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833899?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:30","pubTimestamp":1741865400,"startTime":"0","endTime":"0","summary":"LONDON, March 13, 2025 /PRNewswire/ -- Virax Biolabs Group Limited  , an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced it has presented data evaluating the role of T-Cell dysfunction in post-acute infection syndromes  at the World Immune Regulation Meeting  in Davos, Switzerland.\"This data highlights the critical role of T-Cell exhaustion in immune dysfunction, particularly in PAIS conditions like long COVID, ME/CFS and chronic Lyme disease,\" said Nigel McCracken, Chief Operating Officer at Virax Biolabs. \"In conjunction, we have initiated a number of clinical validation studies to evaluate the performance our T-Cell-based diagnostic in assessing the link between T-Cell dysfunction and symptoms of chronic fatigue and cognitive impairment.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/virax-biolabs-presents-data-t-113000013.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/virax-biolabs-presents-data-t-113000013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4212","VRAX","BK4175","POST","BK4583"],"gpt_icon":0},{"id":"2517916270","title":"Virax Biolabs to Present at 19th World Immune Regulation Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916270","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916270?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:30","pubTimestamp":1741177800,"startTime":"0","endTime":"0","summary":"LONDON, March 5, 2025 /PRNewswire/ -- Virax Biolabs Group Limited  , an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company's management will present at the19th World Immune Regulation Meeting , which will take place March 12-15, 2025, in Davos, Switzerland.Additionally, the Company will be showcasing its portfolio of immune profiling products for research use at Booth 116, and management will be available for discussions with research organizations and potential customers.WIRM 2025 is an esteemed conference where approximately 600 scientists and clinicians from around the globe gather to discuss the latest advancements in immunology. This four-day event combines top-tier scientific lectures, informal networking, and a poster exhibition, all set against the stunning backdrop of Davos.Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/virax-biolabs-present-19th-world-123000194.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/virax-biolabs-present-19th-world-123000194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VRAX","BK4583","BK4175"],"gpt_icon":0},{"id":"2514098731","title":"Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2514098731","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514098731?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:00","pubTimestamp":1740484800,"startTime":"0","endTime":"0","summary":"Company Positioned to Support Public Health through Vaccine Efficacy Testing and Data-Driven Insights into Patients' Immune Profiles to Empower Informed Decisions on Vaccination. LONDON, Feb. 25, 2025 /PRNewswire/ -- Virax Biolabs Group Limited   believes that its technology aligns with the United States Department of Health and Human Services' commitment to prioritizing transparency on vaccine efficacy. This initiative is essential for empowering the public with the information needed to make informed health decisions.Virax Biolabs recognizes the essential role vaccines play in public health and is committed to ensuring vaccine efficacy. The Company asserts the importance of transparency regarding vaccine effectiveness and how individual immune profiles impact vaccination decisions, enabling informed, empowered choices about personal health.Virax Biolabs is positioned to advance vaccine transparency in collaboration with companies developing vaccines. Our cutting-edge technology enabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/virax-biolabs-believes-technology-aligns-120000244.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/virax-biolabs-believes-technology-aligns-120000244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VRAX","BK4175","BK4583","UBCP","BK4211"],"gpt_icon":0},{"id":"2514982720","title":"EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency","url":"https://stock-news.laohu8.com/highlight/detail?id=2514982720","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514982720?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:45","pubTimestamp":1740483919,"startTime":"0","endTime":"0","summary":"On Thursday, Virax Biolabs Group Limited  said it supports the U.S. Department of Health and Human Services’ focus on vaccine efficacy transparency, emphasizing the need for accessible information to aid informed health decisions.The company underscores the role of transparency in understanding vaccine effectiveness and the impact of individual immune responses on vaccination outcomes.Also Read: EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland. Earlier this month, the U.S. Senate voted to confirm Robert F. Kennedy Jr. as the head of the Department ofHealth and Human Services.The Senate voted 52 to 48 to confirm Kennedy as health secretary, with Sen.Mitch McConnell as the only Republican who voted “no.” All Democrats voted against the nomination.As secretary of health, Kennedy will oversee several critical health agencies, including the Food and Drug Administration, the Centers for Disease Control and Prevention, and the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-virax-biolabs-says-tech-114519974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GCC","BK4583","BK4009","HHS","VRAX","BK4175","COSM"],"gpt_icon":0},{"id":"2505025590","title":"BRIEF-Cosmos Health Signs Expanded Exclusive Distribution Agreement With Virax Biolabs For Avian Influenza Virus PCR Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=2505025590","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505025590?lang=en_us&edition=fundamental","pubTime":"2025-01-24 04:40","pubTimestamp":1737664837,"startTime":"0","endTime":"0","summary":"BRIEF-Cosmos Health Signs Expanded Exclusive Distribution Agreement With Virax Biolabs For Avian Influenza Virus PCR Kits Jan 23  - Cosmos Health Inc COSM.O:COSMOS HEALTH: EXPANDED EXCLUSIVE DISTRIBUTION AGREEMENT WITH VIRAX BIOLABS FOR AVIAN INFLUENZA VIRUS PCR KITS IN SAUDI ARABIA, UAE, QATAR, KUWAITFurther company coverage: COSM.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250123:nFWN3OJ1W2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRAX","BK4583","BK4175","COSM"],"gpt_icon":0},{"id":"2505815025","title":"Cosmos Health: Expanded Exclusive Distribution Agreement With Virax Biolabs for Avian Influenza Virus Pcr Kits in Saudi Arabia, UAE, Qatar, Kuwait","url":"https://stock-news.laohu8.com/highlight/detail?id=2505815025","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505815025?lang=en_us&edition=fundamental","pubTime":"2025-01-24 04:39","pubTimestamp":1737664754,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250123:nFWN3OJ1W2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4175","BK4583","COSM","VRAX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-12-18","symbol":"VRAX","defaultRemindTime":1702909800000,"type":"split","dateTimestamp":1702875600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRAX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRAX","date":"2025-07-17","current":-0.659755,"percent":0.742156,"low":-275.112697,"twenty":-4.54658,"median":-1.215696,"eighty":-0.556076,"high":-0.208096,"avg":-7.91265,"sd":26.957843,"marketCap":3998941},"quantilePoints":[{"date":"2022-07-08","current":-66.13286,"twenty":-66.13286,"median":-66.13286,"eighty":-66.13286,"marketCap":56870490},{"date":"2022-07-15","current":-66.13286,"twenty":-66.13286,"median":-66.13286,"eighty":-66.13286,"marketCap":56870490},{"date":"2022-07-22","current":-136.762754,"twenty":-66.13286,"median":-66.13286,"eighty":-66.13286,"marketCap":117608173},{"date":"2022-07-29","current":-72.691945,"twenty":-233.31673,"median":-66.13286,"eighty":-66.13286,"marketCap":62510929},{"date":"2022-08-05","current":-147.268496,"twenty":-197.992753,"median":-72.691945,"eighty":-66.13286,"marketCap":126642512},{"date":"2022-08-12","current":-46.607149,"twenty":-160.810735,"median":-96.316826,"eighty":-66.13286,"marketCap":79643554},{"date":"2022-08-19","current":-37.529593,"twenty":-157.903057,"median":-66.13286,"eighty":-66.13286,"marketCap":64131582},{"date":"2022-08-26","current":-21.000314,"twenty":-152.195394,"median":-66.13286,"eighty":-45.834879,"marketCap":35885903},{"date":"2022-09-02","current":-26.826208,"twenty":-146.191578,"median":-66.13286,"eighty":-33.302433,"marketCap":45841348},{"date":"2022-09-09","current":-22.897117,"twenty":-143.013512,"median":-66.13286,"eighty":-27.422346,"marketCap":39127211},{"date":"2022-09-16","current":-17.884138,"twenty":-135.633149,"median":-66.13286,"eighty":-23.926809,"marketCap":30560898},{"date":"2022-09-23","current":-19.001897,"twenty":-126.968597,"median":-46.607149,"eighty":-22.991957,"marketCap":32470954},{"date":"2022-09-30","current":-21.339028,"twenty":-107.88023,"median":-42.542571,"eighty":-22.219687,"marketCap":36464708},{"date":"2022-10-07","current":-14.496991,"twenty":-97.245668,"median":-37.529593,"eighty":-21.013863,"marketCap":24772849},{"date":"2022-10-14","current":-10.974357,"twenty":-90.353395,"median":-30.010126,"eighty":-20.593856,"marketCap":18753278},{"date":"2022-10-21","current":-9.484013,"twenty":-71.380128,"median":-25.606834,"eighty":-18.812217,"marketCap":16206537},{"date":"2022-10-28","current":-10.364671,"twenty":-66.13286,"median":-23.947132,"eighty":-16.298954,"marketCap":17711429},{"date":"2022-11-04","current":-11.245329,"twenty":-66.13286,"median":-23.642289,"eighty":-13.209875,"marketCap":19216322},{"date":"2022-11-11","current":-9.822728,"twenty":-66.13286,"median":-22.72776,"eighty":-11.475655,"marketCap":16785342},{"date":"2022-11-18","current":-9.619499,"twenty":-66.13286,"median":-22.219687,"eighty":-11.082746,"marketCap":16438059},{"date":"2022-11-25","current":-10.209221,"twenty":-66.13286,"median":-21.339028,"eighty":-10.500157,"marketCap":17445793},{"date":"2022-12-02","current":-10.434424,"twenty":-66.13286,"median":-21.034185,"eighty":-10.434424,"marketCap":17830626},{"date":"2022-12-09","current":-7.581848,"twenty":-66.13286,"median":-20.864828,"eighty":-10.209221,"marketCap":12956066},{"date":"2022-12-16","current":-4.892919,"twenty":-66.13286,"median":-20.322885,"eighty":-10.133667,"marketCap":8361152},{"date":"2022-12-23","current":-4.278864,"twenty":-66.13286,"median":-19.001897,"eighty":-9.958213,"marketCap":7311839},{"date":"2022-12-30","current":-5.479949,"twenty":-66.13286,"median":-17.884138,"eighty":-9.831651,"marketCap":9364285},{"date":"2023-01-06","current":-5.545258,"twenty":-66.13286,"median":-16.732508,"eighty":-9.592402,"marketCap":9475887},{"date":"2023-01-13","current":-5.588797,"twenty":-56.002618,"median":-15.005063,"eighty":-9.297358,"marketCap":9550288},{"date":"2023-01-20","current":-5.641345,"twenty":-48.192334,"median":-13.413104,"eighty":-8.963095,"marketCap":9640083},{"date":"2023-01-27","current":-5.855296,"twenty":-46.525857,"median":-11.922759,"eighty":-6.753099,"marketCap":10005688},{"date":"2023-02-03","current":-4.04516,"twenty":-46.024559,"median":-11.666078,"eighty":-5.973895,"marketCap":10517504},{"date":"2023-02-10","current":-4.484754,"twenty":-43.125161,"median":-11.380815,"eighty":-5.812049,"marketCap":11660460},{"date":"2023-02-17","current":-3.947472,"twenty":-38.870904,"median":-11.143714,"eighty":-5.600208,"marketCap":10263513},{"date":"2023-02-24","current":-3.16745,"twenty":-37.692176,"median":-10.838871,"eighty":-5.553215,"marketCap":8235440},{"date":"2023-03-03","current":-3.453606,"twenty":-36.12054,"median":-10.500157,"eighty":-5.470941,"marketCap":8979452},{"date":"2023-03-10","current":-4.846609,"twenty":-30.430133,"median":-10.32448,"eighty":-5.290731,"marketCap":12601290},{"date":"2023-03-17","current":-3.859653,"twenty":-30.132063,"median":-10.209221,"eighty":-4.938023,"marketCap":10035183},{"date":"2023-03-24","current":-4.192895,"twenty":-29.210759,"median":-10.147797,"eighty":-4.616544,"marketCap":10901618},{"date":"2023-03-31","current":-4.158213,"twenty":-26.582333,"median":-10.059086,"eighty":-4.4713,"marketCap":10811445},{"date":"2023-04-06","current":-3.886739,"twenty":-25.606834,"median":-10.025956,"eighty":-4.332796,"marketCap":10105607},{"date":"2023-04-14","current":-3.582378,"twenty":-23.981003,"median":-9.89971,"eighty":-4.294629,"marketCap":9314261},{"date":"2023-04-21","current":-2.571227,"twenty":-23.981003,"median":-9.822728,"eighty":-4.188731,"marketCap":6685248},{"date":"2023-04-28","current":-2.625044,"twenty":-23.91326,"median":-9.585627,"eighty":-4.155181,"marketCap":6825172},{"date":"2023-05-05","current":-2.039043,"twenty":-23.777774,"median":-9.458543,"eighty":-4.125923,"marketCap":5301557},{"date":"2023-05-12","current":-2.093457,"twenty":-23.642289,"median":-9.246913,"eighty":-4.043186,"marketCap":5443035},{"date":"2023-05-19","current":-2.53535,"twenty":-23.371317,"median":-8.933068,"eighty":-3.946535,"marketCap":6591965},{"date":"2023-05-26","current":-2.391241,"twenty":-22.897117,"median":-7.390425,"eighty":-3.859653,"marketCap":6217280},{"date":"2023-06-02","current":-2.332043,"twenty":-22.626145,"median":-6.328215,"eighty":-3.741569,"marketCap":6063364},{"date":"2023-06-09","current":-2.451037,"twenty":-22.341624,"median":-6.005424,"eighty":-3.616451,"marketCap":6372751},{"date":"2023-06-16","current":-1.164573,"twenty":-22.233236,"median":-5.931857,"eighty":-3.518731,"marketCap":6355649},{"date":"2023-06-23","current":-1.243068,"twenty":-22.219687,"median":-5.855292,"eighty":-3.415912,"marketCap":6784038},{"date":"2023-06-30","current":-1.277161,"twenty":-21.867423,"median":-5.736681,"eighty":-3.275301,"marketCap":6970099},{"date":"2023-07-07","current":-1.232578,"twenty":-21.311931,"median":-5.627082,"eighty":-2.774653,"marketCap":6726789},{"date":"2023-07-14","current":-1.279128,"twenty":-21.176446,"median":-5.588797,"eighty":-2.58199,"marketCap":6980833},{"date":"2023-07-21","current":-1.340429,"twenty":-21.054508,"median":-5.550138,"eighty":-2.520042,"marketCap":7315383},{"date":"2023-07-28","current":-1.255525,"twenty":-21.000314,"median":-5.479949,"eighty":-2.451157,"marketCap":6852022},{"date":"2023-08-04","current":-1.316499,"twenty":-20.973217,"median":-5.393621,"eighty":-2.393155,"marketCap":7184783},{"date":"2023-08-11","current":-1.285684,"twenty":-20.810634,"median":-5.254746,"eighty":-2.346275,"marketCap":7016614},{"date":"2023-08-18","current":-1.188324,"twenty":-20.593856,"median":-4.944474,"eighty":-2.278945,"marketCap":6485269},{"date":"2023-08-25","current":-1.226022,"twenty":-20.485467,"median":-4.846609,"eighty":-2.169518,"marketCap":6691008},{"date":"2023-09-01","current":-1.173572,"twenty":-19.916427,"median":-4.553544,"eighty":-2.10745,"marketCap":6404762},{"date":"2023-09-08","current":-1.112271,"twenty":-19.374483,"median":-4.478747,"eighty":-2.093457,"marketCap":6070212},{"date":"2023-09-15","current":-1.237823,"twenty":-19.001897,"median":-4.429,"eighty":-1.351903,"marketCap":6755414},{"date":"2023-09-22","current":-1.180128,"twenty":-18.764797,"median":-4.324597,"eighty":-1.334037,"marketCap":6440543},{"date":"2023-09-29","current":-1.016222,"twenty":-18.06027,"median":-4.306563,"eighty":-1.316499,"marketCap":5546023},{"date":"2023-10-06","current":-1.053592,"twenty":-17.288,"median":-4.292339,"eighty":-1.31322,"marketCap":5749973},{"date":"2023-10-13","current":-0.972295,"twenty":-16.8138,"median":-4.190813,"eighty":-1.309353,"marketCap":5306292},{"date":"2023-10-20","current":-0.98344,"twenty":-16.298954,"median":-4.158213,"eighty":-1.286209,"marketCap":5367119},{"date":"2023-10-27","current":-0.82609,"twenty":-16.055079,"median":-4.158213,"eighty":-1.283848,"marketCap":4508380},{"date":"2023-11-03","current":-0.852315,"twenty":-15.309906,"median":-4.129452,"eighty":-1.278538,"marketCap":4651503},{"date":"2023-11-10","current":-0.81855,"twenty":-14.347956,"median":-4.125923,"eighty":-1.266016,"marketCap":4467232},{"date":"2023-11-17","current":-0.816911,"twenty":-13.616332,"median":-4.044666,"eighty":-1.238872,"marketCap":4458287},{"date":"2023-11-24","current":-0.780055,"twenty":-13.074389,"median":-4.039708,"eighty":-1.232578,"marketCap":4257145},{"date":"2023-12-01","current":-0.762166,"twenty":-12.085916,"median":-3.947472,"eighty":-1.215204,"marketCap":4159517},{"date":"2023-12-08","current":-0.558922,"twenty":-11.922759,"median":-3.905358,"eighty":-1.204714,"marketCap":3050312},{"date":"2023-12-15","current":-0.545371,"twenty":-11.855016,"median":-3.859653,"eighty":-1.188324,"marketCap":2976359},{"date":"2023-12-22","current":-0.46471,"twenty":-11.748111,"median":-3.758635,"eighty":-1.180128,"marketCap":2536154},{"date":"2023-12-29","current":-5.344173,"twenty":-11.715298,"median":-3.767147,"eighty":-1.180128,"marketCap":29165790},{"date":"2024-01-05","current":-0.418239,"twenty":-11.616857,"median":-3.728737,"eighty":-1.180128,"marketCap":2282539},{"date":"2024-01-12","current":-0.365129,"twenty":-11.475655,"median":-3.662498,"eighty":-1.172392,"marketCap":1992692},{"date":"2024-01-19","current":-0.279965,"twenty":-11.407912,"median":-3.608688,"eighty":-1.160722,"marketCap":1938346},{"date":"2024-01-26","current":-0.322378,"twenty":-11.380815,"median":-3.552528,"eighty":-1.100076,"marketCap":2231998},{"date":"2024-02-02","current":-0.269501,"twenty":-11.299523,"median":-3.471157,"eighty":-1.065394,"marketCap":1865903},{"date":"2024-02-09","current":-0.285296,"twenty":-11.123392,"median":-3.353973,"eighty":-1.016615,"marketCap":1975259},{"date":"2024-02-16","current":-0.280443,"twenty":-11.001454,"median":-3.270565,"eighty":-0.995307,"marketCap":1941654},{"date":"2024-02-23","current":-0.303616,"twenty":-10.865968,"median":-2.870805,"eighty":-0.976753,"marketCap":2102093},{"date":"2024-03-01","current":-0.328348,"twenty":-10.622094,"median":-2.632817,"eighty":-0.906207,"marketCap":2273329},{"date":"2024-03-08","current":-0.322481,"twenty":-10.500157,"median":-2.571227,"eighty":-0.848774,"marketCap":2232709},{"date":"2024-03-15","current":-0.28997,"twenty":-10.473864,"median":-2.53834,"eighty":-0.823336,"marketCap":2007617},{"date":"2024-03-22","current":-0.26609,"twenty":-10.406523,"median":-2.499472,"eighty":-0.80924,"marketCap":1842284},{"date":"2024-03-28","current":-0.240504,"twenty":-10.348595,"median":-2.451635,"eighty":-0.786162,"marketCap":1665141},{"date":"2024-04-05","current":-0.280077,"twenty":-10.273268,"median":-2.416057,"eighty":-0.762494,"marketCap":1939122},{"date":"2024-04-12","current":-0.26609,"twenty":-10.225192,"median":-2.391839,"eighty":-0.727746,"marketCap":1842284},{"date":"2024-04-19","current":-0.231874,"twenty":-10.199665,"median":-2.3739,"eighty":-0.671296,"marketCap":1605385},{"date":"2024-04-26","current":-0.238799,"twenty":-10.161442,"median":-2.332043,"eighty":-0.559446,"marketCap":1653332},{"date":"2024-05-03","current":-0.208096,"twenty":-10.155984,"median":-2.280021,"eighty":-0.541979,"marketCap":1440760},{"date":"2024-05-10","current":-0.235387,"twenty":-10.134056,"median":-2.214245,"eighty":-0.467366,"marketCap":1629713},{"date":"2024-05-17","current":-0.267318,"twenty":-10.118751,"median":-2.158635,"eighty":-0.423219,"marketCap":1850787},{"date":"2024-05-24","current":-0.284171,"twenty":-10.05246,"median":-2.110798,"eighty":-0.37708,"marketCap":1967465},{"date":"2024-05-31","current":-0.371844,"twenty":-10.025956,"median":-2.099437,"eighty":-0.365021,"marketCap":2574474},{"date":"2024-06-07","current":-0.672048,"twenty":-10.025956,"median":-2.06625,"eighty":-0.358198,"marketCap":4652948},{"date":"2024-06-14","current":-0.590174,"twenty":-9.971762,"median":-1.412829,"eighty":-0.363656,"marketCap":4086092},{"date":"2024-06-21","current":-0.586763,"twenty":-9.928655,"median":-1.34633,"eighty":-0.365021,"marketCap":4062473},{"date":"2024-06-28","current":-0.402547,"twenty":-9.90895,"median":-1.340757,"eighty":-0.365021,"marketCap":2787045},{"date":"2024-07-05","current":-0.375255,"twenty":-9.894166,"median":-1.337233,"eighty":-0.365107,"marketCap":2598093},{"date":"2024-07-12","current":-0.388901,"twenty":-9.8452,"median":-1.321088,"eighty":-0.370501,"marketCap":2692569},{"date":"2024-07-15","current":-0.385489,"twenty":-9.833882,"median":-1.318793,"eighty":-0.371844,"marketCap":2668950},{"date":"2024-08-02","current":-0.385489,"twenty":-9.831651,"median":-1.316499,"eighty":-0.371844,"marketCap":2668950},{"date":"2024-08-09","current":-0.368432,"twenty":-9.809945,"median":-1.314697,"eighty":-0.36579,"marketCap":2550855},{"date":"2024-08-16","current":-0.474186,"twenty":-9.730951,"median":-1.311909,"eighty":-0.369114,"marketCap":3283045},{"date":"2024-08-23","current":-1.767111,"twenty":-9.60595,"median":-1.312728,"eighty":-0.371844,"marketCap":12234657},{"date":"2024-08-30","current":-3.262817,"twenty":-9.538207,"median":-1.31486,"eighty":-0.371844,"marketCap":21970297},{"date":"2024-09-06","current":-2.598646,"twenty":-9.484013,"median":-1.316499,"eighty":-0.371844,"marketCap":17498082},{"date":"2024-09-13","current":-1.695891,"twenty":-9.458543,"median":-1.332479,"eighty":-0.375088,"marketCap":11419344},{"date":"2024-09-20","current":-1.631408,"twenty":-9.308407,"median":-1.340757,"eighty":-0.375255,"marketCap":10985148},{"date":"2024-09-27","current":-1.244513,"twenty":-9.280784,"median":-1.340593,"eighty":-0.375255,"marketCap":8379975},{"date":"2024-10-04","current":-1.25741,"twenty":-9.213041,"median":-1.330922,"eighty":-0.375255,"marketCap":8466814},{"date":"2024-10-11","current":-1.154238,"twenty":-9.008136,"median":-1.316499,"eighty":-0.382078,"marketCap":7772101},{"date":"2024-10-18","current":-1.005928,"twenty":-8.933068,"median":-1.314535,"eighty":-0.385046,"marketCap":6773451},{"date":"2024-10-25","current":-1.657201,"twenty":-8.182391,"median":-1.314042,"eighty":-0.385489,"marketCap":11158826},{"date":"2024-10-31","current":-1.444409,"twenty":-7.701957,"median":-1.315679,"eighty":-0.385489,"marketCap":9725981},{"date":"2024-11-08","current":-1.32834,"twenty":-7.275571,"median":-1.315444,"eighty":-0.385489,"marketCap":8944429},{"date":"2024-11-15","current":-1.225168,"twenty":-6.604465,"median":-1.315152,"eighty":-0.388219,"marketCap":8249716},{"date":"2024-11-22","current":-1.28009,"twenty":-6.251646,"median":-1.313548,"eighty":-0.394359,"marketCap":8423394},{"date":"2024-11-29","current":-1.299886,"twenty":-6.09784,"median":-1.314535,"eighty":-0.395724,"marketCap":8553653},{"date":"2024-12-06","current":-1.128327,"twenty":-6.014988,"median":-1.311745,"eighty":-0.397283,"marketCap":7424744},{"date":"2024-12-13","current":-1.062343,"twenty":-5.984053,"median":-1.309615,"eighty":-0.400857,"marketCap":6990549},{"date":"2024-12-20","current":-1.247098,"twenty":-5.959648,"median":-1.304206,"eighty":-0.402547,"marketCap":8206296},{"date":"2024-12-27","current":-1.141524,"twenty":-5.936061,"median":-1.299886,"eighty":-0.405276,"marketCap":7511583},{"date":"2025-01-03","current":-1.458247,"twenty":-5.89973,"median":-1.304206,"eighty":-0.410734,"marketCap":9595722},{"date":"2025-01-10","current":-1.544027,"twenty":-5.855296,"median":-1.310434,"eighty":-0.416192,"marketCap":10160177},{"date":"2025-01-17","current":-1.412058,"twenty":-5.855288,"median":-1.311909,"eighty":-0.418239,"marketCap":9291785},{"date":"2025-01-24","current":-1.36587,"twenty":-5.797636,"median":-1.314535,"eighty":-0.420895,"marketCap":8987848},{"date":"2025-01-31","current":-1.11513,"twenty":-5.708756,"median":-1.314697,"eighty":-0.428197,"marketCap":7337905},{"date":"2025-02-07","current":-1.187713,"twenty":-5.651104,"median":-1.311909,"eighty":-0.440758,"marketCap":7815520},{"date":"2025-02-14","current":-1.2405,"twenty":-5.618524,"median":-1.311418,"eighty":-0.452498,"marketCap":8162877},{"date":"2025-02-21","current":-1.200909,"twenty":-5.600208,"median":-1.308959,"eighty":-0.460272,"marketCap":7902359},{"date":"2025-02-28","current":-1.128327,"twenty":-5.589999,"median":-1.299886,"eighty":-0.464407,"marketCap":7424744},{"date":"2025-03-07","current":-0.897383,"twenty":-5.568529,"median":-1.294334,"eighty":-0.46471,"marketCap":5905060},{"date":"2025-03-14","current":-0.851194,"twenty":-5.553666,"median":-1.28634,"eighty":-0.470396,"marketCap":5601123},{"date":"2025-03-21","current":-0.837997,"twenty":-5.549613,"median":-1.283389,"eighty":-0.476467,"marketCap":5514284},{"date":"2025-03-28","current":-0.818202,"twenty":-5.546159,"median":-1.283203,"eighty":-0.50368,"marketCap":5384025},{"date":"2025-04-04","current":-0.679636,"twenty":-5.506073,"median":-1.278964,"eighty":-0.524592,"marketCap":4472214},{"date":"2025-04-11","current":-0.57835,"twenty":-5.473193,"median":-1.277817,"eighty":-0.535678,"marketCap":3805724},{"date":"2025-04-17","current":-0.679636,"twenty":-5.461182,"median":-1.268638,"eighty":-0.54257,"marketCap":4472214},{"date":"2025-04-25","current":-0.719226,"twenty":-5.407622,"median":-1.264541,"eighty":-0.544754,"marketCap":4732732},{"date":"2025-05-02","current":-0.646644,"twenty":-5.341432,"median":-1.256534,"eighty":-0.550136,"marketCap":4255116},{"date":"2025-05-09","current":-0.699431,"twenty":-5.314026,"median":-1.250961,"eighty":-0.557939,"marketCap":4602473},{"date":"2025-05-16","current":-0.699431,"twenty":-5.269349,"median":-1.250961,"eighty":-0.559971,"marketCap":4602473},{"date":"2025-05-23","current":-0.65984,"twenty":-5.224719,"median":-1.245805,"eighty":-0.566173,"marketCap":4341956},{"date":"2025-05-30","current":-0.632127,"twenty":-5.134787,"median":-1.243791,"eighty":-0.573117,"marketCap":4159593},{"date":"2025-06-06","current":-0.640704,"twenty":-4.950925,"median":-1.2405,"eighty":-0.574137,"marketCap":4216034},{"date":"2025-06-13","current":-0.633447,"twenty":-4.925562,"median":-1.237944,"eighty":-0.578244,"marketCap":4168277},{"date":"2025-06-20","current":-0.541069,"twenty":-4.892919,"median":-1.235296,"eighty":-0.573117,"marketCap":3560403},{"date":"2025-06-27","current":-0.508077,"twenty":-4.846609,"median":-1.232578,"eighty":-0.557283,"marketCap":3343306},{"date":"2025-07-03","current":-0.608895,"twenty":-4.752739,"median":-1.226022,"eighty":-0.545165,"marketCap":3690666},{"date":"2025-07-11","current":-0.63762,"twenty":-4.616544,"median":-1.220842,"eighty":-0.552487,"marketCap":3864775},{"date":"2025-07-17","current":-0.659755,"twenty":-4.54658,"median":-1.215696,"eighty":-0.556076,"marketCap":3998941}],"updateTime":1752877095206}}}